Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

UroGen Pharma Ltd. URGN

Full chart Compare
Set alert

Price alert · URGN

All alert types
25.73 USD -3.01 (-10.47%)

At closeNov 5, 2026, 5:30 PM EST

25.73 0.00 0.00%

After hours · Nov 5, 5:30 PM ET

25.07 Day range 28.42
16.50 52-week range 50.81
YTD
+9.86%
1 year
+33.25%

Financial health

Altman Z-Score

-2.05 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -7.3×
FY 2016: -87.4×FY 2017: -18.1×FY 2018: -9.0×FY 2019: -6.8×FY 2020: -3.1×FY 2021: -1.9×FY 2022: -1.9×FY 2023: -4.2×FY 2024: -3.6×FY 2025: -7.3×
FY 2016 5y median -3.6× FY 2025
P/S 10.3×
FY 2016: 9.5×FY 2017: 44.3×FY 2018: 601×FY 2019: 38058×FY 2020: 33.3×FY 2021: 4.4×FY 2022: 3.1×FY 2023: 5.2×FY 2024: 5.1×FY 2025: 10.3×
FY 2016 5y median 5.1× FY 2025
P/B -10.7×
FY 2016: 10.3×FY 2017: 5.3×FY 2018: 7.5×FY 2019: 3.8×FY 2020: 4.1×FY 2021: 25.3×FY 2022: -2.3×FY 2023: -6.6×FY 2024: -51.9×FY 2025: -10.7×
FY 2016 5y median -6.6× FY 2025
P/FCF -6.9×
FY 2016: 47.9×FY 2017: -36.7×FY 2018: -17.9×FY 2019: -9.6×FY 2020: -3.7×FY 2021: -2.5×FY 2022: -2.3×FY 2023: -5.6×FY 2024: -4.7×FY 2025: -6.9×
FY 2016 5y median -4.7× FY 2025
EV/EBITDA -8.4×
FY 2016: 144×FY 2017: -16.4×FY 2018: -7.5×FY 2019: -5.9×FY 2020: -2.8×FY 2021: -1.6×FY 2022: -3.2×FY 2023: -7.2×FY 2024: -4.3×FY 2025: -8.4×
FY 2016 5y median -4.3× FY 2025
EV/Sales 10.4×
FY 2016: 8.3×FY 2017: 39.8×FY 2018: 512×FY 2019: 35442×FY 2020: 28.9×FY 2021: 3.5×FY 2022: 3.8×FY 2023: 5.3×FY 2024: 4.5×FY 2025: 10.4×
FY 2016 5y median 4.5× FY 2025
FCF Yield -14.4%
FY 2016: 2.1%FY 2017: -2.7%FY 2018: -5.6%FY 2019: -10.4%FY 2020: -27.3%FY 2021: -40.3%FY 2022: -43.4%FY 2023: -17.7%FY 2024: -21.3%FY 2025: -14.4%
FY 2016 5y median -21.3% FY 2025

Profitability

Gross Margin 88.7%
FY 2016: 99.8%FY 2017: 92.6%FY 2018: -59.8%FY 2019: 100.0%FY 2020: 91.4%FY 2021: 89.3%FY 2022: 88.1%FY 2023: 88.7%FY 2024: 90.2%FY 2025: 88.7%
FY 2016 5y median 88.7% FY 2025
Operating Margin -113.7%
FY 2016: 4.6%FY 2017: -244.5%FY 2018: -6842.2%FY 2019: -608211.1%FY 2020: -1074.2%FY 2021: -192.1%FY 2022: -122.8%FY 2023: -79.2%FY 2024: -107.1%FY 2025: -113.7%
FY 2016 5y median -113.7% FY 2025
Net Margin -139.8%
FY 2016: -11.1%FY 2017: -245.2%FY 2018: -6707.2%FY 2019: -584144.4%FY 2020: -1088.9%FY 2021: -230.7%FY 2022: -170.6%FY 2023: -123.6%FY 2024: -140.4%FY 2025: -139.8%
FY 2016 5y median -140.4% FY 2025
ROE 145.5%
FY 2016: -11.9%FY 2017: -29.2%FY 2018: -84.0%FY 2019: -58.3%FY 2020: -133.3%FY 2021: -1317.2%FY 2022: 122.9%FY 2023: 156.8%FY 2024: 1441.3%FY 2025: 145.5%
FY 2016 5y median 145.5% FY 2025
ROIC -81.1%
FY 2016: 4.0%FY 2017: -29.1%FY 2018: -85.7%FY 2019: -59.9%FY 2020: -126.0%FY 2021: -94.8%FY 2022: -70.8%FY 2023: -44.6%FY 2024: -40.4%FY 2025: -81.1%
FY 2016 5y median -70.8% FY 2025
ROA -76.6%
FY 2016: -8.4%FY 2017: -26.5%FY 2018: -73.1%FY 2019: -52.0%FY 2020: -105.3%FY 2021: -92.5%FY 2022: -80.9%FY 2023: -57.3%FY 2024: -44.4%FY 2025: -76.6%
FY 2016 5y median -76.6% FY 2025

Growth (YoY)

Revenue 21.4%
FY 2016: 0.0%FY 2017: -53.5%FY 2018: -86.2%FY 2019: -98.4%FY 2020: 65450.0%FY 2021: 307.2%FY 2022: 34.0%FY 2023: 28.5%FY 2024: 9.3%FY 2025: 21.4%
FY 2016 FY 2025
Operating Income -29.0%
FY 2016: 106.4%FY 2017: -2600.0%FY 2018: -286.9%FY 2019: -41.8%FY 2020: -15.8%FY 2021: 27.2%FY 2022: 14.4%FY 2023: 17.1%FY 2024: -47.7%FY 2025: -29.0%
FY 2016 FY 2025
EPS (diluted) -7.8%
FY 2016: 97.1%FY 2017: -1187.5%FY 2018: -133.0%FY 2019: -2.1%FY 2020: -20.4%FY 2021: 15.9%FY 2022: 3.4%FY 2023: 25.9%FY 2024: 16.6%FY 2025: -7.8%
FY 2016 FY 2025
Free Cash Flow -67.7%
FY 2016: 146.7%FY 2017: -381.7%FY 2018: -285.0%FY 2019: -88.3%FY 2020: -50.1%FY 2021: 20.0%FY 2022: -2.5%FY 2023: 12.8%FY 2024: -26.8%FY 2025: -67.7%
FY 2016 FY 2025

Financial Health

Current Ratio 4.0×
FY 2016: 7.0×FY 2017: 10.6×FY 2018: 7.6×FY 2019: 7.6×FY 2020: 5.4×FY 2021: 5.1×FY 2022: 5.4×FY 2023: 5.4×FY 2024: 6.0×FY 2025: 4.0×
FY 2016 5y median 5.4× FY 2025
Quick Ratio 3.7×
FY 2016: 7.0×FY 2017: 10.5×FY 2018: 7.6×FY 2019: 7.6×FY 2020: 5.3×FY 2021: 4.9×FY 2022: 5.2×FY 2023: 5.2×FY 2024: 5.8×FY 2025: 3.7×
FY 2016 5y median 5.2× FY 2025
Debt / Equity -1.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -1.1×FY 2023: -1.5×FY 2024: -14.0×FY 2025: -1.2×
FY 2016 5y median -1.2× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: -21.1×FY 2017: 1.9×FY 2018: 1.3×FY 2019: 0.4×FY 2020: 0.4×FY 2021: 0.4×FY 2022: -0.6×FY 2023: -0.1×FY 2024: 0.5×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025
Interest Coverage -3.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -385×FY 2020: -355×FY 2021: -5.3×FY 2022: -9.4×FY 2023: -4.5×FY 2024: -7.7×FY 2025: -3.7×
FY 2016 5y median -5.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31